Mepolizumab for Eosinophilic COPD
N Engl J Med
.
2018 Feb 15;378(7):680-1.
doi: 10.1056/NEJMc1715454.
Authors
Yang Xia
1
,
Wen Li
1
,
Huahao Shen
1
2
Affiliations
1
Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
2
huahaoshen@zju.edu.cn
PMID:
29446291
DOI:
10.1056/NEJMc1715454
No abstract available
Publication types
Letter
Comment
MeSH terms
Anti-Asthmatic Agents*
Antibodies, Monoclonal, Humanized*
Asthma
Eosinophils
Humans
Pulmonary Disease, Chronic Obstructive
Substances
Anti-Asthmatic Agents
Antibodies, Monoclonal, Humanized
mepolizumab